AWARDPURCHASE ORDERSmall business
Purchase order 75F40123P00396BRACANE COMPANY
Overview
Award facts
- Net obligations
- $873.3K
- $873,298of $873.3K potential value
- Outlays (paid to date)
- $518.23K
- $518.23K paid of $873.3K obligated$518,225
- Period of performance
- Sep 11, 2023 to Sep 14, 2027
- Ends in 9 months
- Modifications
- 4
- Latest action Sep 8, 2026
- Contract type
- Purchase order
- PIID 75F40123P00396
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
THIS IS A PURCHASE ORDER FOR CLINICAL OPERATIONS AND CLINICAL TRIAL SITE MONITORING.
Dates and value
- Award date
- Signed on Sep 11, 2023
- Current value
- $873,298Base and exercised options
- Potential value (if all options are exercised)
- $873,298
Obligations by fiscal year of action
- FY2026: $226,235
- FY2025: $220,865
- FY2024: $215,638
- FY2023: $210,561
Total across 4 fiscal years: $873,298
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 8, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameBRACANE COMPANY
LocationPLANO, TX
UEIKRGPL7AL94P8
CAGE code3B2Y7
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBRACANE COMPANY
Business types and certifications
Women-ownedWomen-owned small business (WOSB)Economically disadvantaged WOSB (EDWOSB)Minority-ownedSelf-certified small disadvantaged businessSBA 8(a) program participantFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Silver Spring, Montgomery County, Maryland 20993-0002
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 11, 2023Base obligation at award: $210,561
- Latest action
- Sep 8, 2026 — Option exercisedModification P00004; obligation change +$226,235
- Latest substantive action
- Sep 8, 2026 — Option exercisedModification P00004; obligation change +$226,235
- Actions by type
- Base award1
- Option exercised3
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $226,235
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- 075-2025/2025-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- 25.3: Other goods and services from Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression